Clinical Trial Update: CLDN6/GPC3/Mesothelin/AXL-CAR-NK Cell Therapy for Advanced Solid Tumors [Phase 1]

View source ↗

Summary

A phase 1 trial evaluating CLDN6/GPC3/Mesothelin/AXL-CAR-NK cell therapy for advanced solid tumors is currently recruiting, including stage IV ovarian cancer, r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Cancer
• Ovarian Cancer
• Testicular Cancer

Drugs mentioned

• CLDN6/GPC3/Mesothelin/AXL-CAR-NK cell therapy

Snippet

Sponsor: Second Affiliated Hospital of Guangzhou Medical University | Conditions: Stage IV Ovarian Cancer, Testis Cancer, Refractory | Phase 1 | Status: RECRUITING